Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...

A new commentary published in Annals of Internal Medicine from Roy Gulick, MD, Chief, Division of Infectious Diseases and ...

A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found ... in the April issue of The Journal of Nuclear Medicine. Interleukin-13 receptor α-2 (IL13Rα2 ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Some people may be more vulnerable to infections and illnesses than others and several factors can be to blame Here’s what a ...

Lipids are the fatty molecules that make up cellular membranes, creating a protective barrier that regulates what enters and ...

Scientists have uncovered why vaccines can elicit a stronger immune response if they are administered in the same arm.

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

FREDERICK, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...

Welcome to the Adaptive Biotechnologies first-quarter 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

Phase 2 ARCHER Data Support Therapeutic Potential for ANX007 to Preserve Vision in Patients who have Dry Age-related Macular Degeneration (AMD) with Geographic Atrophy (GA) Phase 3 ARCHER II Trial ...